Search research articles
Contact Us
Filters
Showing results (131-140 of 627) with videos related to
Page
of 63
Sort By:
Diabetes, Obesity & Metabolism
|
March 1, 2017
Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS-R trials
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, et al.
The American Journal of Cardiology
|
April 19, 2017
Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF])
Tharian S Cherian, Peter Shrader, Gregg C Fonarow, et al.
European Journal of Heart Failure
|
January 23, 2025
Canagliflozin reduces oral loop diuretic intensification in patients with type 2 diabetes: A participant-level pooled analysis of the CANVAS and CREDENCE trials
Safia Chatur, Muthiah Vaduganathan, Robert A Fletcher, et al.
The New England Journal of Medicine
|
November 15, 2021
Milvexian for the Prevention of Venous Thromboembolism
Jeffrey I Weitz, John Strony, Walter Ageno, et al.
American Heart Journal
|
March 17, 2022
Independence of clinical events committees: A consensus statement from clinical research organizations
Ernest Spitzer, Alexander C Fanaroff, C Michael Gibson, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
May 1, 2010
Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: a subgroup analysis from the SYNERGY trial
Marc Cohen, Glenn N Levine, Karen S Pieper, et al.
Clinical Cardiology
|
March 12, 2014
Comparison of clinical trial outcome patterns in patients following acute coronary syndromes and in patients with chronic stable atherosclerosis
Kenneth W Mahaffey, Daniel M Wojdyla, Karen S Pieper, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 14, 2025
<i>CARS</i> 2 Hypermethylation Is a Risk Factor for Stage B Heart Failure and Hospitalizations in the Project Baseline Health Study
Jessica A Regan, Jordan Franklin, Kalyani Kottilil, et al.
The American Journal of Cardiology
|
April 2, 2017
Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II])
Benjamin A Steinberg, DaJuanicia N Simon, Laine Thomas, et al.
Journal of Thrombosis and Thrombolysis
|
February 11, 2012
Activated partial thromboplastin time measurement is not associated with clinical outcomes in patients with high-risk non-ST-segment elevation acute coronary syndromes treated with unfractionated heparin
Michael P Thomas, Kenneth W Mahaffey, Karen Chiswell, et al.
Page
of 63
Search research articles
Search
Showing results (131-140 of 627) with videos related to
Sort By:
Page
of 63
Diabetes, Obesity & Metabolism
|
March 1, 2017
Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS-R trials
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, et al.
The American Journal of Cardiology
|
April 19, 2017
Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF])
Tharian S Cherian, Peter Shrader, Gregg C Fonarow, et al.
European Journal of Heart Failure
|
January 23, 2025
Canagliflozin reduces oral loop diuretic intensification in patients with type 2 diabetes: A participant-level pooled analysis of the CANVAS and CREDENCE trials
Safia Chatur, Muthiah Vaduganathan, Robert A Fletcher, et al.
The New England Journal of Medicine
|
November 15, 2021
Milvexian for the Prevention of Venous Thromboembolism
Jeffrey I Weitz, John Strony, Walter Ageno, et al.
American Heart Journal
|
March 17, 2022
Independence of clinical events committees: A consensus statement from clinical research organizations
Ernest Spitzer, Alexander C Fanaroff, C Michael Gibson, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
May 1, 2010
Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: a subgroup analysis from the SYNERGY trial
Marc Cohen, Glenn N Levine, Karen S Pieper, et al.
Clinical Cardiology
|
March 12, 2014
Comparison of clinical trial outcome patterns in patients following acute coronary syndromes and in patients with chronic stable atherosclerosis
Kenneth W Mahaffey, Daniel M Wojdyla, Karen S Pieper, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 14, 2025
<i>CARS</i> 2 Hypermethylation Is a Risk Factor for Stage B Heart Failure and Hospitalizations in the Project Baseline Health Study
Jessica A Regan, Jordan Franklin, Kalyani Kottilil, et al.
The American Journal of Cardiology
|
April 2, 2017
Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II])
Benjamin A Steinberg, DaJuanicia N Simon, Laine Thomas, et al.
Journal of Thrombosis and Thrombolysis
|
February 11, 2012
Activated partial thromboplastin time measurement is not associated with clinical outcomes in patients with high-risk non-ST-segment elevation acute coronary syndromes treated with unfractionated heparin
Michael P Thomas, Kenneth W Mahaffey, Karen Chiswell, et al.
Page
of 63